Alphatec Holdings, INC 10-Q quarterly reports

Alphatec Holdings, Inc. (ATEC) filed its Form 10-Q for the quarter ended June 30, 2026, detailing a 15% increase in revenue driven by product volume and portfolio expansion, alongside significant debt management activities.

Alphatec Holdings reported a 14% increase in revenue for Q1 2026, reaching $192.1 million, but also saw its net loss widen to $33.9 million.

Alphatec Holdings, Inc. reported a 30% increase in third-quarter revenue and a significant reduction in net loss, driven by strong product adoption and strategic debt refinancing.

Alphatec Holdings, a medical technology company, announced a 27% increase in Q2 2025 revenue and a significant positive swing in operating cash flow, driven by product adoption and market share expansion, while strategically refinancing its debt.

Alphatec Holdings announces a 22% increase in revenue for Q1 2025, driven by product volume growth and strategic financial maneuvers including a convertible notes offering and debt repurchase.

Alphatec Holdings, a medical technology company focused on spinal disorders, announced a 27% increase in revenue for the third quarter of 2024, while still experiencing net losses.

Alphatec Holdings, a medical technology company focused on spinal disorders, announced a 25% increase in revenue for the second quarter of 2024 compared to the same period last year, driven by increased product adoption and a growing surgeon user base.

Alphatec Holdings saw a 27% increase in revenue in the first quarter of 2024 compared to the same period last year, primarily due to increased product volume.